Diana S. M. Buist, PhD, MPH

home / authors / diana-s-m-buist-phd-mph

Articles

January 10th 2014

Electronic Health Risk Assessment Adoption in an Integrated Healthcare System

Diana S. M. Buist, PhD, MPH Nora Knight Ross, MA Robert J. Reid, MD, PhD David C. Grossman, MD, MPH

Significant additional outreach and engagement strategies and incentives are likely required to increase adoption and ongoing use of health risk assessment tools among target populations.

November 6th 2009

Delayed Radiotherapy for Breast Cancer Patients in Integrated Delivery Systems

Heather Taffet Gold, PhD Soe Soe Thwin, PhD Diana S. M. Buist, PhD, MPH Terry S. Field, DSc Feifei Wei, PhD Marianne Ulcickas Yood, DSc, MPH Timothy L. Lash, DSc Virginia P. Quinn, PhD Ann M. Geiger, PhD Rebecca A. Silliman, MD, PhD

Among older women in 5 integrated delivery systems, 14% experienced delayed radiotherapy for breast cancer, even though they had insurance and access to care.

Latest Updated Articles

FDA approval stamp | Image Credit: Surendra - stock.adobe.com

Published: November 15th 2024 | Updated: November 19th 2024

FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation

What We’re Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Program for Elderly Care; Health Care Not a Top Issue Among Voters

Published: April 1st 2024 | Updated: November 5th 2024

What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues

Clinician giving patient a diagnosis | Image Credit: Pcess609 - stock.adobe.com

Published: October 21st 2024 | Updated: October 24th 2024

Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions

Hurricane | Image credit: Satoshi Kina - stock.adobe.com

Published: September 26th 2024 | Updated: October 1st 2024

Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Acute myeloid leukemia | Image: St Jude Children's Research Center

Published: September 19th 2024 | Updated: November 21st 2024

Institute for Value-Based Medicine®: Speakers Use AML Studies to Illustrate Effects of Disparities, Neighborhood Stress on Outcomes

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions